Page last updated: 2024-12-05
dimethylcarbamyl chloride
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
dimethylcarbamyl chloride: searcher request; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6598 |
| CHEMBL ID | 1527556 |
| CHEBI ID | 82280 |
| SCHEMBL ID | 924 |
| MeSH ID | M0041102 |
Synonyms (98)
| Synonym |
|---|
| carbamyl chloride,n-dimethyl- |
| tl 389 |
| n,n-dimethylcarbamyl chloride |
| dimethylcarbamic acid chloride |
| wln: gvn1&1 |
| n,n-dimethylcarbamoyl chloride |
| n,n-dimethylcarbamidoyl chloride |
| chloroformic acid dimethylamide |
| carbamoyl chloride, dimethyl- |
| (dimethylamino)carbonyl chloride |
| dimethylcarbamoyl chloride |
| nsc122671 |
| dimethylcarbamidoyl chloride |
| nsc-122671 |
| dimethylcarbamyl chloride |
| carbamic chloride, dimethyl- |
| 79-44-7 |
| dimethylcarbamic chloride |
| carbamic acid,n,n-dimethyl,chloride |
| inchi=1/c3h6clno/c1-5(2)3(4)6/h1-2h |
| NCGC00091795-01 |
| dimethyl carbamoyl chloride |
| hsdb 2656 |
| dimethylamid kyseliny chlormravenci [czech] |
| chlorid kyseliny dimethylkarbaminove [czech] |
| rcra waste number u097 |
| nsc 122671 |
| rcra waste no. u097 |
| un2262 |
| einecs 201-208-6 |
| dimethylkarbamoylchlorid [czech] |
| dimethyl carbamyl chloride |
| brn 0878197 |
| n,n-dimethylcarbamic acid chloride |
| dimethylcarbamoylchloride |
| ccris 257 |
| dimethylchloroformamide |
| carbamyl chloride, n,n-dimethyl- |
| dimethylcarbamyl chloride, 98% |
| D0695 |
| AKOS000120154 |
| NCGC00091795-02 |
| NCGC00091795-03 |
| C19175 |
| NCGC00254074-01 |
| tox21_300116 |
| tox21_201334 |
| NCGC00258886-01 |
| dtxcid30512 |
| cas-79-44-7 |
| dtxsid1020512 , |
| dimethylaminoformyl chloride |
| carbamic chloride, n,n-dimethyl- |
| chlorid kyseliny dimethylkarbaminove |
| unii-5d54s95gt6 |
| dimethylcarbamoyl chloride [un2262] [corrosive] |
| dimethylamid kyseliny chlormravenci |
| dimethylkarbamoylchlorid |
| ec 201-208-6 |
| 5d54s95gt6 , |
| FT-0629527 |
| STL370332 |
| dimethylcarbamoyl chloride [hsdb] |
| dimethylcarbamoyl chloride [iarc] |
| BBL027301 |
| SCHEMBL924 |
| CHEBI:82280 , |
| chloroformic acid dimethyl amide |
| n,n-dimethyl-carbamoyl chloride |
| dimethylcarbarnyl chloride |
| dimethyl carbamylchloride |
| dimethylcarbamoylchlorid |
| me2ncocl |
| dimethyl carbamic acid chloride |
| n,n-dimethylcarbamic chloride |
| n,n-dimethyl-carbamoylchloride |
| dimethylcarbamylchloride |
| dimethyl carbamoylchloride |
| (ch3)2ncocl |
| n,n-dimethyl-carbamic chloride |
| n,n-dimethyl carbamyl chloride |
| dimethyl-carbamoyl chloride |
| n,n-dimethyl-carbamic acid chloride |
| clc(o)n(ch3)2 |
| dimethylaminocarbonyl chloride |
| n,n-dimethyl carbamoyl chloride |
| dimethylcarbamylchlorid |
| dirnethylcarbamoyl chloride |
| n,n-dimethylchloroformamide |
| n,n-dimethylcarbamoylchloride |
| W-104263 |
| CHEMBL1527556 |
| mfcd00000635 |
| F0001-2079 |
| dimethylcarbamoyl chloride, purum, >=98.0% (at) |
| n,n-dimethylaminoformyl chloride |
| 22055-85-2 |
| Q2563907 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (1)
| Class | Description |
|---|---|
| halide | Any heteroatomic molecular entity that is a chemical compound of halogen with other chemical elements. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Protein Targets (5)
Potency Measurements
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 33.7725 | 0.0007 | 14.5928 | 83.7951 | AID1259369; AID1259392 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 39.8107 | 0.0112 | 12.4002 | 100.0000 | AID1030 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 15.8489 | 0.0013 | 18.0743 | 39.8107 | AID926; AID938 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 54.9410 | 0.0002 | 29.3054 | 16,493.5996 | AID743075 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 61.1306 | 0.0017 | 23.8393 | 78.1014 | AID743083 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Research
Studies (15)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 11 (73.33) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 31.29
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (31.29) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (6.67%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 14 (93.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||